Kodiak Sciences Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
KOD$108.06+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Operating expenses | |||
| Research and development | $206,298 | $267,591 | $217,340 |
| General and administrative | 71,023 | 73,788 | 49,711 |
| Total operating expenses | 277,321 | 341,379 | 267,051 |
| Loss from operations | (277,321) | (341,379) | (267,051) |
| Interest income | 16,733 | 7,071 | 298 |
| Interest expense | (13) | (18) | (47) |
| Other income (expense), net | 110 | 503 | (190) |
| Net loss | $(260,491) | $(333,823) | $(266,990) |
| Net loss per common share, basic and diluted | $(4.97) | $(6.39) | $(5.16) |
| Weighted-average shares of common stock outstanding used in computing net loss per common share, basic and diluted | 52,414,256 | 52,249,620 | 51,788,918 |
| Other comprehensive income (loss) | |||
| Change in unrealized gains (losses) related to available-for-sale debt securities, net of tax | 1,307 | (1,307) | (53) |
| Total other comprehensive income (loss) | 1,307 | (1,307) | (53) |
| Comprehensive loss | $(259,184) | $(335,130) | $(267,043) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.